Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
382
382 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HRS-717Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HRS-7172Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer
- HRS5580Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Prevention of Postoperative Nausea and Vomiting
- HRX215Phase 21 trial
HepaRegeniX GmbH · Liver Resection, Colorectal Carcinoma Liver Metastases
- HW201877Phase 21 trial
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Inflammatory Bowel Disease (IBD)
- HX009Phase 21 trial
Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma
- HY-0102Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
- ICP-192Phase 21 trial
Beijing InnoCare Pharma Tech Co., Ltd. · Intrahepatic Cholangiocarcinoma (ICC)
- IDP-001Phase 21 trial
InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma
- IMT-009Phase 21 trial
Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer
- INV-8989Phase 21 trial
Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC
- IO-108Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- IPN01194Phase 21 trial
Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma
- IvaltinostatPhase 21 trial
CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma
- JMT203Phase 21 trial
Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia
- JYP0015Phase 21 trial
Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)
- KAN-101Phase 21 trial
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA · Celiac Disease, Coeliac Disease
- KN713Phase 21 trial
New Cancer Cure-Bio Co.,Ltd. · Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- KQB198Phase 21 trial
Kumquat Biosciences Inc. · GIST - Gastrointestinal Stromal Tumor, GIST, GIST Metastatic Cancer
- Kylo 0603Phase 21 trial
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Metabolic Dysfunction-Associated Steatoic Liver Disease
- LG00313112Phase 21 trial
LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer
- LP-184Phase 21 trial
Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM
- LUM015Phase 21 trial
Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer
- LY3537021Phase 21 trial
Eli Lilly · Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions
- MDX2001Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer
- MerestinibLY2801653Phase 21 trial
Eli Lilly · Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer
- MHS-1031Panosyl-isomaltooligosaccharidePhase 21 trial
Microbiome Health Sciences · Gastroesophageal Reflux
- MIV-818Phase 21 trial
Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases
- ML-016iNPG-pDoxPhase 21 trial
BrYet US, Inc. · Advanced Solid Tumor With Lung and/or Liver Involvement
- MN-001Phase 21 trial
MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease
- MR001Phase 21 trial
Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)
- MT-201Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- MT-501Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- narmafotinibPhase 21 trial
Amplia Therapeutics Limited · Pancreatic Cancer Metastatic
- NDI-101150Phase 21 trial
Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- NDX-3315Phase 21 trial
NexEos Diagnostics, Inc. · Eosinophilic Esophagitis
- NDX-3324Phase 21 trial
NexEos Diagnostics, Inc. · Eosinophilic Esophagitis
- NEO212POH-TMZPhase 21 trial
Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult
- NHS7108Phase 21 trial
Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality
- NKT2152Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- NST-6179Phase 21 trial
NorthSea Therapeutics B.V. · Intestinal Failure Associated Liver Disease
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- OPK-88006Phase 21 trial
OPKO Health, Inc. · MASH
- PBP1510Phase 21 trial
Prestige Biopharma Limited · Pancreatic Cancer
- PEGPH20Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- PepinemabPhase 21 trial
Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma
- PM1009Phase 21 trial
Biotheus Inc. · HCC, Liver Cancer
- PN20Phase 21 trial
Chongqing Peg-Bio Biopharm Co., Ltd. · Thrombocytopenia Associated With Chronic Liver Disease
- Q702Phase 21 trial
Qurient Co., Ltd. · Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.